Indole-3-carbinol induces G1 cell cycle arrest and apoptosis through aryl hydrocarbon receptor in THP-1 monocytic cell line

The estrogenic effect of trigonelline and 3,3-diindolymethane on cell growth in non-malignant colonocytes

(2016) Gyhye Yoo et al.   FOOD AND CHEMICAL TOXICOLOGY

Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation

(2016) Aishwarya Kundu et al.   MOLECULAR CARCINOGENESIS

Indole-3-Carbinol Synergizes with and Restores Fludarabine Sensitivity in Chronic Lymphocytic Leukemia Cells Irrespective of p53 Activity and Treatment Resistances

(2015) G. Perez-Chacon et al.   CLINICAL CANCER RESEARCH

Environment-induced lentigines: formation of solar lentigines beyond ultraviolet radiation

(2015) Motoki Nakamura et al.   EXPERIMENTAL DERMATOLOGY

Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells

(2015) Majid Safa et al.   TUMOR BIOLOGY

Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients

(2014) Mina Javaheri-Kermani et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells

(2014) E F O'Donnell et al.   Cell Death & Disease

Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death

(2013) C. Hinterleitner et al.   APOPTOSIS

OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis

(2013) Li-Yuan Bai et al.   BIOCHEMICAL PHARMACOLOGY

Role of aryl hydrocarbon receptor in cancer

(2013) Shaolong Feng et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Functional analyses of recombinant mouse hepcidin-1 in cell culture and animal model

(2013) Yaghoub Yazdani et al.   BIOTECHNOLOGY LETTERS

Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling

(2013) Chun Wang et al.   CARCINOGENESIS

Indole-3-Carbinol Inhibits Nasopharyngeal Carcinoma Growth through Cell Cycle Arrest In Vivo and In Vitro

(2013) Zhe Chen et al.   PLoS One

Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis

(2012) L. Ouyang et al.   CELL PROLIFERATION

The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis

(2012) Stephan Lindsey et al.   Stem Cell Reviews and Reports

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007

(2011) G. M. Dores et al.   BLOOD

Activation of the Aryl Hydrocarbon Receptor AhR Promotes Retinoic Acid-Induced Differentiation of Myeloblastic Leukemia Cells by Restricting Expression of the Stem Cell Transcription Factor Oct4

(2011) R. P. Bunaciu et al.   CANCER RESEARCH

Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cells

(2011) Miaoqing Shen et al.   LEUKEMIA & LYMPHOMA

In vivo pharmacodynamics of indole-3-carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: Involvement of Nrf2 and cell cycle/apoptosis signaling pathways

(2011) Tien-Yuan Wu et al.   MOLECULAR CARCINOGENESIS

Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells

(2010) Hee-Sook Choi et al.   FOOD AND CHEMICAL TOXICOLOGY

Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells

(2010) Anthony E. Boitano et al.   SCIENCE

The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis

(2009) Y. Fan et al.   CANCER RESEARCH

Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: A tumor promoting event?

(2008) S. Ray et al.   BIOCHEMICAL PHARMACOLOGY

Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy

(2008) Paul L. Nguyen et al.   JOURNAL OF CLINICAL ONCOLOGY